Advances in the medical management of benign prostatic hyperplasia.
Jewett
Michael A S
MA
Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ont.
Klotz
Laurence H
LH
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D017292:Doxazosin / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000453:epidemiology; D011471:Prostatic Neoplasms / Q000453:epidemiology
D000317:Adrenergic alpha-Antagonists; D004791:Enzyme Inhibitors; D018120:Finasteride; D017292:Doxazosin